METHOD FOR THE PREPARATION OF SPIROKETAL-SUBSTITUTED CYCLICAL KETOENOLES
Patent Information
- Application Number
- DE502017016513
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-08-04
- Filing Date
- 2017-07-31
- Publication Date
- 2024-11-14
- Estimated Expiration
- 2037-07-31
AI Technical Summary
The existing process for producing spiroketal-substituted cyclic ketoenols is inefficient due to transketalization and the formation of unwanted byproducts, leading to costly and time-consuming purification steps.
A new process involving Schotten-Baumann acylation of spiroketal-substituted amino acids with phenylacetic acid chloride under nitrogen conditions, followed by esterification with a diol under acidic conditions, and subsequent Dieckmann cyclization to produce spiroketal-substituted cyclic ketoenols.
This process simplifies the production of spiroketal-substituted cyclic ketoenols by reducing byproduct formation and eliminating the need for costly purification, resulting in a more efficient and economical synthesis.
Description
[0001] The invention relates to a novel process for the preparation of spiroketal-substituted cyclic ketoenols, which can be used as insecticides, acaricides, or herbicides. The present invention also relates to novel intermediates for the preparation of spiroketal-substituted cyclic ketoenols.
[0002] It has already been known that certain spiroketal-substituted cyclic ketoenols exhibit insecticidal, acaricidal or herbicidal activity ( WO 99 / 16748 ;WO 06 / 089633). A known synthesis (A) of such spiroketal-substituted cyclic ketoenols starts from correspondingly spiroketal-substituted cyclohexanones of general formula (I), which are converted in a Bucherer-Bergs reaction to the spiroketal-substituted hydantoins of general formula (II). Alkaline saponification of these hydantoins yields the spiroketal-substituted amino acids of general formula (III). These amino acids are then esterified by known methods of organic chemistry (for example, by reaction with an alcohol R 7< -OH and thionyl chloride) to the spiroketal-substituted amino acid esters of general formula (IV; R 7< is C 1 -C 6 -alkyl). These amino acid esters are then acylated at the nitrogen with phenylacetic acid chlorides of general formula (VII) to give the compounds of general formula (VIII).The compounds of general formula (VIII) are then cyclized in a Dieckmann reaction by the action of a strong base such as potassium tertiary butylate or sodium methoxide to form the spiroketal-substituted cyclic ketoenols of general formula (XI). This process (A) is depicted in Scheme 1. A significant disadvantage of this process (A) is that the esterification of the amino acids of general formula (III) under acidic conditions almost always also results in at least partial transketalization of the cyclic ketal to an acyclic ketal (geminal bis(alkoxy) compound) of general formula (V). Furthermore, it has been shown in practice that even under essentially anhydrous conditions, ketones of general formula (VI) can also be formed, albeit only in minor amounts.The ester is then obtained as a mixture of at least two products of the general formulas (IV) and (V), which also leads to corresponding product mixtures in the subsequent steps of process (A). In addition, the easy hydrolyzability of the acyclic ketals also leads to the formation of N-acylated ketones of the general formula (X) (identical to the products of the N-acylation of the keto compounds of the general formula (VI)). Thus, after N-acylation with a phenylacetic acid chloride of the general formula (VII), the amides of the general formulas (VIII), (IX), and (X) are obtained. The Dieckmann cyclization then leads to a mixture of the cyclic ketoenols of the general formulas (XI), (XII), and (XIII).Therefore, to obtain a pure product of general formula (XI) under technical conditions (e.g., if purification of the target compound by chromatography is not possible), it is essential to react this mixture of compounds of general formulas (XI), (XII), and (XIII) with a diol of general formula (XIV) in the presence of an acid catalyst in an additional step to form the single compound of general formula (XI). This additional step is time-consuming, costly, and uneconomical.
[0003] There was therefore a need for a simpler, shorter process for the preparation of spiroketal-substituted cyclic ketoenols of the general formula (XI).
[0004] It has now been found that the synthesis of spiroketal-substituted cyclic ketoenols of the general formula (XI) can be surprisingly simplified by acylating the spiroketal-substituted amino acids of the general formula (III) at the nitrogen in a first step (1) under Schotten-Baumann conditions with a phenylacetic acid chloride of the general formula (VII), thus obtaining the amides of the general formula (XV); then, in the second step (2) of the process according to the invention, an esterification is carried out under acidic conditions with the diol of the general formula (XIV), whereby a mixture of the esters of the general formula (XVI) and diesters of the general formula (XVII) can be obtained; and then, in the third step (3) of the process according to the invention, the Dieckmann cyclization is carried out to give the spiroketal-substituted cyclic ketoenols of the general formula (XI). The process (B) according to the invention is shown in Scheme 2.
[0005] The present invention thus includes a novel process (B) for the preparation of spiroketal-substituted cyclic ketoenols of the general formula (XI), characterized in that in the first step (1) of the process, spiroketal-substituted amino acids of the general formula (III) in which the remains R 1< to R 6< independently represent hydrogen, methyl, ethyl or phenyl stand and nfor 0 or 1 stands, in the presence of a base with a phenylacetic acid chloride of the general formula (VII) in which the radicals R 8< to R 12< independently of one another represent hydrogen, methyl, ethyl, fluoroalkyl having one or two carbon atoms and one to five fluorine atoms, halogen, methoxy, ethoxy, trifluoromethoxy or phenyl optionally substituted by methyl, ethyl, methoxy, ethoxy or halogen, to compounds of the general formula (XV) in which n and the radicals R 1< to R 6< and R 8< to R 12< have the meanings given above, then in the second step (2) of the process (B) according to the invention, a compound of the general formula (XV) with an α, -Diol of the general formula (XIV) HO-(CR 1< R 2< ) n -CR 3< R 4< -CR 5< R 6< -OH (XIV) , in which n and the radicals R 1< to R 6< have the meanings given above and in the specific individual case are identical to those in the compound of the general formula (XV), in the presence of an acid as catalyst to the mono- and diesters of the general formulas (XVI) and (XVII) in which n and the radicals R 1< to R 6< and R 8< to R 12< have the meanings given above and both n and the corresponding radicals R 1< to R 6< and R 8< to R 12< are identical at both positions of the compounds of the general formulas (XVI) or (XVII), are esterified; then, in the third step (3) of the process (B) according to the invention, the compounds of the general formulas (XVI) and (XVII), in which n and the radicals R 1< to R 6< and R 8< to R 12< have the meanings given above, are reacted with a strong base to give the spiroketal-substituted cyclic ketoenols of the general formula (XI) in which n and the radicals R 1< to R 6< and R 8< to R 12< have the meanings given above. R 1< to R 6< means R 1< , R 2< , R 3< , R 4< , R 5< , R 6< . R 8< to R 12< means R 8< , R 9< , R 10< , R 11< , R 12< . In the formulas (III), (VII), (XV), (XIV), (XVI), (XVII), (XI), R 1< to R 6< independently of one another preferably represent hydrogen, methyl or ethyl, R 8< to R 12< independently of one another preferably represent hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy, trifluoromethoxy or phenyl which is optionally substituted by methyl, ethyl, methoxy, ethoxy, fluorine, chlorine or bromine, n is preferably 0 or 1; R 1< to R 6< independently of one another particularly preferably represent hydrogen or methyl, R 8< to R 12< independently of one another particularly preferably represent hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy or phenyl which is optionally substituted by methyl, ethyl, methoxy, ethoxy, fluorine or chlorine, n is particularly preferably 0 or 1;R 3< to R 6< independently of one another are likewise particularly preferably hydrogen or methyl, R 8< to R 12< independently of one another are likewise particularly preferably hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy or phenyl optionally substituted by methyl, methoxy, fluorine or chlorine, n is likewise particularly preferably 0; R 3< to R 6< independently of one another are very particularly preferably hydrogen or methyl, R 8< to R 12< independently of one another are very particularly preferably hydrogen, methyl or chlorine, n is very particularly preferably 0. ;
[0006] In highlighted form, n stands for 0, R 3< to R 6< for hydrogen, R 8< for methyl, R 9< for hydrogen, R 10< for chlorine, R 11< for hydrogen, R 12< for methyl.
[0007] In highlighted form, n stands for 0, R 3< to R 6< for hydrogen, R 8< for methyl, R 9< for hydrogen, R 10< for methyl, R 11< for hydrogen, R 12< for methyl.
[0008] In highlighted form, n stands for 0, R 3< for hydrogen, R 4< for methyl, R 5< for hydrogen, R 6< for methyl, R 8< for methyl, R 9< for hydrogen, R 10< for hydrogen, R 11< for methyl, R 12< for hydrogen.
[0009] In highlighted form, n stands for 1, R 1< for hydrogen, R 2< for hydrogen, R 3< for methyl, R 4< for methyl, R 5< for hydrogen, R 6< for hydrogen, R 8< for methyl, R 9< for hydrogen, R 10< for chlorine, R 11< for hydrogen, R 12< for methyl.
[0010] In highlighted form, n stands for 1, R 1< to R 6< for hydrogen, R 8< for methyl, R 9< for hydrogen, R 10< for chlorine, R 11< for hydrogen, R 12< for methyl.
[0011] In the formulas (I), (II) and (XIII) described in process A, R 1< , R 2< , R 3< , R 4< , R 5< , R 6< , R 8< , R 9< , R 10< , R 11< , R 12< and n have the meanings given above.
[0012] In formulas (IV), (VIII), (IX), (X) and (XII) described in process A, R 1< , R 2< , R 3< , R 4< , R 5< , R 6< , R 8< , R 9< , R 10< , R 11< , R 12< and n have the meanings given above and R 7< stands for C 1 -C 6 -alkyl. It is particularly emphasized that n is 0; R 3< to R 6< stand for hydrogen; R 8< and R 12< stand for methyl; R 9< and R 11< stand for hydrogen; R 10< stands for chlorine and R 7< stands for methyl: Compound of formula (IV-1): Compound of formula (VIII-1): Compound of formula (IX-1): Compound of formula (X-1): Compound of formula (XII-1): In formulas (V) and (VI) described in Process A, R 7< represents C 1 -C 6 alkyl. It is emphasized that R 7< represents methyl: Compound of formula (V-1): Compound of formula (VI-1): (Me = CH 3 = Methyl)
[0013] The first step (1) of process (B) according to the invention is carried out in a solvent that is inert under the reaction conditions. Examples of suitable solvents include: dichloromethane, toluene, ortho-, meta-, or para-xylene, mesitylene, chlorobenzene, ortho-dichlorobenzene, acetonitrile, butyronitrile, N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, 1,4-dioxane, ethyl acetate, butyl acetate, water, or mixtures of these solvents. Preferred solvents are toluene, ortho-, meta- or para-xylene, chlorobenzene, acetonitrile, butyronitrile, tetrahydrofuran, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, ethyl acetate, butyl acetate, water or mixtures of these solvents.Particularly preferred are mixtures of toluene, ortho-, meta- or para-xylene, chlorobenzene, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether with water (so-called Schotten-Baumann conditions).
[0014] Organic bases such as trimethylamine, triethylamine, piperidine, morpholine, pyridine, or inorganic bases such as ammonia, lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, or calcium carbonate can be used as bases in the first step (1) of process (B) according to the invention. Sodium hydroxide and potassium hydroxide are preferred.
[0015] Solid inorganic bases can be used as solids or in the form of their aqueous solutions. Aqueous solutions are preferred.
[0016] The base is usually used in an amount that results in a pH value between 10 and 14. A pH value between 11 and 13 is preferred.
[0017] The first step (1) of the process (B) according to the invention is carried out at temperatures between -5 and 50°C; preferably between 0 and 30°C.
[0018] The isolation of the compounds of general formula (XV) is carried out by known conventional methods of organic chemistry such as filtration, phase separation or extraction.
[0019] In the second step (2) of process (B) according to the invention, solvents that are inert under the reaction conditions can be used. Examples of suitable solvents are: dichloromethane, toluene, ortho-, meta-, or para-xylene, mesitylene, chlorobenzene, ortho-dichlorobenzene, acetonitrile, butyronitrile, tetrahydrofuran, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, 1,4-dioxane, or mixtures of these solvents. Toluene, ortho-, meta-, or para-xylene, chlorobenzene, acetonitrile, butyronitrile, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, or mixtures of these solvents are preferred.
[0020] The α, -diol of the general formula (XIV) is used in an amount of at least 0.5 mol, based on 1 mol of the compound of the general formula (XV). It is also possible to use any excess of α, -diol of the general formula (XIV) and thus to use it simultaneously as a solvent.
[0021] The second step (2) of process (B) according to the invention is carried out in the presence of a catalytic amount of an acid. Examples of suitable acids include hydrogen chloride, sulfuric acid, methanesulfonic acid, trifluoromethanesulfonic acid, para-toluenesulfonic acid, or acidic ion exchange resins such as Amberlite. Sulfuric acid or para-toluenesulfonic acid is preferably used. Sulfuric acid is particularly preferred.
[0022] The acid is used in amounts of 0.01 to 20 percent by weight, based on the compound of general formula (XV). 0.05 to 10 percent by weight is preferred.
[0023] The second step (2) of the process (B) according to the invention is carried out at temperatures between 20 and 150°C; preferably between 50 and 120°C.
[0024] The isolation of the compounds of general formulas (XVI) and (XVII) is carried out by conventional methods of organic chemistry such as filtration, phase separation or extraction.
[0025] In the third step (3) of process (B) according to the invention, solvents that are inert under the reaction conditions can be used. Examples of suitable solvents include: toluene, ortho-, meta-, or para-xylene, mesitylene, chlorobenzene, ortho-dichlorobenzene, acetonitrile, butyronitrile, tetrahydrofuran, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, 1,4-dioxane, N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, methanol, ethanol, 1-butanol, tertiary butanol, or mixtures of these solvents. Preferred solvents are N,N-dimethylformamide, N,N-dimethylacetamide, N-methylpyrrolidone, methanol, tertiary butanol, or mixtures of these solvents.
[0026] Bases that can be used in the third step (3) of process (B) according to the invention include, for example, sodium hydroxide, potassium hydroxide, sodium methylate, potassium methylate, sodium ethylate, potassium ethylate, sodium tertiary butylate, or potassium tertiary butylate. Sodium hydroxide, sodium methylate, and potassium tertiary butylate are preferred. Sodium methylate is particularly preferred.
[0027] The bases are used in an amount of 0.9 to 4 molar equivalents, based on the compounds of general formulas (XVI) and (XVII). Preferably, 1 to 3.5 molar equivalents are used.
[0028] The temperature in the third step (3) of process (B) according to the invention is between 20 and 150°C. Preferably, the temperature is between 40 and 100°C.
[0029] The isolation of the compounds of general formula (XI) after adjusting the pH of the reaction mixture to a value between 0 and 8 is carried out by known conventional methods of organic chemistry such as filtration, phase separation or extraction.
[0030] The compounds of formula (III) are partly known ( WO 06 / 089633 ), some are new or can be manufactured using the processes described there.
[0031] The compounds of formula (VII) are partly known ( WO 97 / 02243 ), some are new or can be manufactured using the processes described there.
[0032] The compounds of formula (XIV) are commercially available.
[0033] The present invention also relates to the novel compound 1-{[(4-chloro-2,6-dimethylphenyl)acetyl] amino} -4-oxocyclohexanecarboxylic acid (XV-1)
[0034] The amino acids of general formula (III) required for the preparation of the compounds of general formula (XV) are partly new. The yields achieved in their preparation by alkaline hydrolysis of the corresponding hydantoins of general formula (II), followed by adjusting the pH to less than 7 and separating the inorganic salts, are not always satisfactory. For example, WO 06 / 089633the preparation of the compound 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylic acid (III-1) by boiling the compound 9,12-dioxa-1,3-diazadispiro[4.2.4.2]tetradecane-2,4-dione (II-1) with 9.8 molar equivalents of potassium hydroxide in the form of 30% potassium hydroxide solution. A pH of 5.2 to 5.3 is then adjusted with concentrated hydrochloric acid. After filtration, the filtrate is concentrated to approximately half its volume by azeotropic distillation with methanol. Potassium chloride is filtered off with suction, and the filtrate is further azeotropically dehydrated with methanol. The isolated yield of the target compound is only 46% of theory. In another known process ( Journal of Agricultural and Food Chemistry 2012 (60) 4779-4787 )The hydantoin (II-1) is refluxed with 7 molar equivalents of sodium hydroxide in the form of 3 N sodium hydroxide solution for 4 days. The mixture is then cooled to 0°C, and the pH is adjusted to 6 with concentrated hydrochloric acid. After filtration, the filtrate is concentrated in vacuo to approximately one-third of its original volume. The precipitated solid is filtered off and dried. The yield of the target compound was only 48% of theoretical.
[0035] There was therefore a need for an improved process for the preparation of the compounds of the general formula (XV #< ) in which the radicals R 8< to R 12< have the meanings given above, suitable precursor.
[0036] It has now been found that instead of the amino acid (III-1) its corresponding sodium or potassium salts of the general formula (XIX) in the M for sodium or potassium stands, can be obtained in a simple manner and with high yield.
[0037] A novel process (C) for the preparation of compounds of the general formula (XIX) is described, characterized in that the hydantoin of the formula (II-1, 9,12-dioxa-1,3-diazadispiro[4.2.4.2]tetradecane-2,4-dione) is heated under reflux with sodium hydroxide solution or potassium hydroxide solution and then the resulting compound of the general formula (XIX) is isolated by filtration.
[0038] The sodium or potassium hydroxide is used in amounts of 1 to 10 molar equivalents. Preferably, between 2 and 7 equivalents are used. If the sodium or potassium hydroxide is used in these amounts, the compound of formula (XIX) precipitates as a solid.
[0039] Sodium hydroxide is particularly preferred.
[0040] The amount of water is between 250 and 1500 mL per mole of hydantoin. Preferably, between 300 and 1000 mL per mole of hydantoin is used.
[0041] The reaction temperature is between 50 and 200°C. Preferably, temperatures are between 80 and 150°C.
[0042] The reaction can also be carried out under reduced or increased pressure.
[0043] The compounds of general formula (XIX) are isolated by simple filtration. After analytical determination of their content, they can be used without further purification in place of the free amino acids in the Schotten-Baumann reaction to produce compound (XV #< ). At the same time, one equivalent of base is saved, which represents a further advantage of this process.
[0044] The following compounds of the general formula (XIX) are mentioned in the M for sodium or potassium stands.
[0045] Preferred is the compound of general formula (XIX) in which M for sodium stands.
[0046] The present invention also relates to a new process (D) for the preparation of compounds of the general formulas (XVI) and (XVII) in which the remains R 1< to R 6< and R 8< to R 12< have the meanings given above and the corresponding radicals R 1< to R 6< and R 8< to R 12< are identical at both positions of the compounds of the general formulas (XVI) or (XVII), and n stands for 0 or 1 and is identical at both positions of the compounds of the general formulas (XVI) or (XVII), characterized in that a keto compound of the general formula (XVIII) in which the radicals R 8< to R 12< have the meanings given above, with an α, -diol of the general formula (XIV) HO-(CR 1< R 2< ) n -CR 3< R 4< -CR 5< R 6< -OH (XIV), in which n and the radicals R 1< to R 6< have the meanings given above and in the specific individual case are identical to those in the compound of the general formula (XVI) or (XVII), in the presence of an acid as catalyst.
[0047] The compounds of the general formula (XVIII) used as starting materials in the process (D) according to the invention are known in principle ( WO 06 / 089633 ).
[0048] In process (D) according to the invention, solvents that are inert under the reaction conditions can be used. Examples of suitable solvents are: dichloromethane, toluene, ortho-, meta-, or para-xylene, mesitylene, chlorobenzene, ortho-dichlorobenzene, acetonitrile, butyronitrile, tetrahydrofuran, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, 1,4-dioxane, or mixtures of these solvents. Toluene, ortho-, meta-, or para-xylene, chlorobenzene, acetonitrile, butyronitrile, 2-methyltetrahydrofuran, cyclopentyl methyl ether, methyl tertiary butyl ether, tertiary amyl methyl ether, or mixtures of these solvents are preferred.
[0049] The α, -diol of the general formula (XIV) is used in an amount of at least 2 mol, based on 1 mol of the compound of the general formula (XVIII). It is also possible to use any excess of α, -diol of the general formula (XIV) and to use this at the same time as a solvent.
[0050] Process (D) according to the invention is carried out in the presence of a catalytic amount of an acid. Examples of suitable acids include hydrogen chloride, sulfuric acid, methanesulfonic acid, trifluoromethanesulfonic acid, para-toluenesulfonic acid, or acidic ion exchange resins such as Amberlite. Sulfuric acid or para-toluenesulfonic acid is preferably used.
[0051] The acid is used in amounts of 0.01 to 20 percent by weight, based on the compound of general formula (XVIII). 0.05 to 10 percent by weight is preferred.
[0052] The process (D) according to the invention is carried out at temperatures between 20 and 150°C; preferably between 50 and 120°C.
[0053] The isolation of the compounds of general formulas (XVI) and (XVII) is carried out by conventional methods of organic chemistry such as filtration, phase separation or extraction.
[0054] The present invention also relates to novel compounds of the general formulas (XVI) and (XVII) in which the remains R 1< to R 6< independently of one another represent hydrogen, methyl, ethyl or phenyl and are identical at both positions of the compounds of the general formulas (XVI) or (XVII), n stands for 0 or 1 and is identical at both positions of the compounds of the general formulas (XVI) or (XVII), and the radicals R 8< to R 12< independently of one another represent hydrogen, methyl, ethyl, fluoroalkyl having one or 2 C atoms and one to five fluorine atoms, halogen, methoxy, ethoxy, trifluoromethoxy or phenyl optionally substituted by methyl, ethyl, methoxy, ethoxy or halogen and are identical at both positions of the compounds of the general formulas (XVI) or (XVII).
[0055] Preference is given to new compounds of the general formulas (XVI) and (XVII) in which the radicals R 1< to R 6< independently represent hydrogen, methyl or ethyl and are identical at both positions of the compounds of the general formulas (XVI) or (XVII), nfor 0 or 1 and is identical at both positions of the compounds of the general formulas (XVI) or (XVII) and the leftovers R 8< to R 12< independently of one another represent hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy, trifluoromethoxy or phenyl optionally substituted by methyl, ethyl, methoxy, ethoxy, fluorine, chlorine or bromine and are identical at both positions of the compounds of the general formulas (XVI) or (XVII).
[0056] Particularly preferred are new compounds of the general formulas (XVI) and (XVII) in which the radicals R 1< to R 6< independently represent hydrogen or methyl and are identical at both positions of the compounds of the general formulas (XVI) or (XVII), nfor 0 stands and the remains R 8< to R 12< independently of one another represent hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy or phenyl optionally substituted by methyl, ethyl, methoxy, ethoxy, fluorine or chlorine and are identical at both positions of the compounds of the general formulas (XVI) or (XVII).
[0057] Particularly preferred are 2-Hydroxyethyl 8-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate ((XVI) with n=0, R 3< to R 6< are hydrogen, R 8< and R 12< are methyl, R 9< and R 11< are hydrogen, R 10< is chlorine). Ethane-1,2-diyl-bis(8-{[(2,5-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate) ((XVII) with n=0, R 3< to R 6< are hydrogen, R 8< and R 12< are methyl, R 9< and R 11< are hydrogen, R 10< is chlorine). 3-Hydroxybutan-2-yl-8-{[(2,5-dimethylphenyl)acetyl]amino}-2,3-dimethyl-1,4-dioxaspiro[4.5]decane-8-carboxylate ((XVI) with n=0, R 3< and R 5< are hydrogen, R 4< and R 6< are methyl, R 8< and R 11< are methyl, R 9< , R 10< and R 12< are hydrogen). 3-Hydroxy-2,2-dimethylpropyl-9-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-3,3-dimethyl-1,5-dioxaspiro[5.5]undecane-9-carboxylate (((XVI) with n=1, R 1< , R 2< , R 5< and R 6< are hydrogen, R 3< and R 4< are methyl, R 9< and R 11< are hydrogen, R 8< and R 12< are methyl, R 10< is chlorine).
[0058] The present invention will be described in more detail by the following examples, without being limited by them. Example 1 2-Hydroxyethyl-8-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate (Ex. XVI-1) and Ethane-1,2-diyl-bis(8-{[(2,5-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate) (Ex. (XVII-1)
[0059]
[0060] To a solution of 3.82 g [10 mmol] of 8-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylic acid in 15 ml of chlorobenzene are added 1.862 g [30 mmol] of ethylene glycol and 10 drops of concentrated sulfuric acid. The reaction mixture is heated to 88 to 103°C for 9 hours. After 5 hours, another 8 drops of concentrated sulfuric acid are added. The reaction mixture is cooled to room temperature, diluted with 30 ml of chlorobenzene, and filtered. The filter residue is washed with petroleum ether, dissolved in methylene chloride, and washed with saturated aqueous sodium bicarbonate solution and water. After drying the organic phase over sodium sulfate and concentrating in vacuo, 3.00 g of colorless solid are obtained, which according to HPLC contains 68.8% 2-hydroxyethyl 8-{[(4-chloro-2,6-dimethylphenyl)acetyl] amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate (48.5% of theory) and 14.1% ethane-1,2-diyl-bis(8-{[(2,5-dimethylphenyl)acetyl] amino} -1,4-dioxaspiro[4.5]decane-8-carboxylate) (10.7% of theory).) enthält.
[0061] LC / MS (ESI positiv): m / e = 426 (MH +< , 1 35< Cl).
[0062] LC / MS (ESI positiv): m / e = 788 (MH +< , 2 35< Cl).
[0063] 1< H-NMR (600 MHz, CDCl 3 ): δ = 1,25-1,35 (m; 2H), 1,6-1,7 (m; 2H), 1,8-1,9 (m; 2H), 2,05-2,15 (m; 2H), 2,24 (s; 6H), 2,9 (s,br; 1H), 3,51 (s; 2H), 3,7 (m, br; 2H), 3,85 (s; 4H), 4,24 (m; 2H), 5,48 (s; 1H), 7,04 (s; 2H) ppm.
[0064] 1< H-NMR (600 MHz, CDCl 3 ): δ = 1,25-1,35 (m; 4H), 1,6-1,7 (m; 4H), 1,8-1,9 (m; 4H), 2,05-2,15 (m; 4H), 2,23-2,25 (s; 12H), 3,48 (s; 4H),, 3,85 (s; 4H), 4,24 (m; 4H), 5,48 (s; 1H), 7,03 (s; 4H) ppm. Example 2 2-Hydroxyethyl-8-{[(4-chlor-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decan-8-carboxylat (Bsp. XVI-1)
[0065]
[0066] To a solution of 1.689 g [5 mmol] of 1-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-4-oxocyclohexanecarboxylic acid in 7.5 ml of chlorobenzene are added 2.483 g [40 mmol] of ethylene glycol and 5 drops of concentrated sulfuric acid. The reaction mixture is heated to 100 to 105°C for 4.5 hours and then stirred with water and methylene chloride at room temperature. The organic phase is separated, washed with water, dried over sodium sulfate, and concentrated in vacuo. This yields 1.98 g of colorless solid, which, according to HPLC, contains 83.1% of the title compound (77.3% of theory). Example 3 3-Hydroxy-2,2-dimethylpropyl-9- {[(4-chloro-2,6-dimethylphenyl)acetyl] amino} -3,3-dimethyl-1,5-dioxaspiro[5.5]undecane-9-carboxylate (Ex. XVI-2)
[0067]
[0068] To a solution of 5.067 g [15 mmol] of 1-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-4-oxocyclohexanecarboxylic acid in 22.5 ml of chlorobenzene are added 12.5 g [120 mmol] of 1,3-dihydroxy-2,2-dimethylpropane and 15 drops of concentrated sulfuric acid. The reaction mixture is heated to 96 to 105°C for 4 hours and then stirred at room temperature with 25 ml of water and 100 ml of methylene chloride. The organic phase is separated, washed three times with 25 ml of water each time, dried over sodium sulfate, and concentrated in vacuo. 6.51 g of colorless solid is obtained, which, according to HPLC, contains 83.5% of the title compound (82.8% of theory).
[0069] LC / MS (ESI positive): m / e = 510 (MH +< , 1 35< Cl).
[0070] 1< H-NMR (600 MHz, CDCl 3 ): δ = 0.92 (s; 6H), 0.94 (s; 6H), 1.3-1.4 (m; 2H), 1.8-1.85 (m; 2H), 1.95-2.1 (m; 4H), 2.30 (s; 6H), 3.32 (s; 2H), 3.45 (d; 4H), 3.56 (s; 2H), 3.97 (s; 2H), 5.42 (s; 1H), 7.1 (s; 2H) ppm. Example 4 2-Hydroxyethyl-8-[(mesitylacetyl)amino]-1,4-dioxaspiro[4.5]decane-8-carboxylate (Ex. XVI-3)
[0071]
[0072] Three drops of concentrated sulfuric acid are added to a suspension of 2.530 g [7 mmol] of 8-[(mesitylacetyl)amino]-1,4-dioxaspiro[4.5]decane-8-carboxylic acid in 19.48 g [313.8 mmol] of ethylene glycol at 85°C. The reaction mixture is stirred at 100°C for 3.5 hours and then taken up in 50 ml of methylene chloride at room temperature. The methylene chloride phase is separated and extracted successively with saturated aqueous sodium bicarbonate solution and water, dried over sodium sulfate, and concentrated in vacuo. This gives 2.90 g of colorless solid, which, according to HPLC, contains 91.9% of the title compound. This corresponds to a yield of 93.9% of theory.
[0073] LC / MS (ESI positive): m / e = 406 (MH +< ), 811 ([2M+H] +< ).
[0074] 1< H-NMR (600 MHz, CDCl 3 ): δ = 1,3-1,4 (m; 2H), 1,6-1,7 (m; 2H), 1,85-1,9 (m; 2H), 2,1-2,2 (m; 2H), 2,29 (s; 9H), 3,1 (s, br; 1H), 3,58 (s; 2H), 3,79 (m, br; 2H), 3,91 (s; 4H), 4,3 (m; 2H), 5,61 (s; 1H), 6,92 (s; 2H) ppm. Example 5 3-Hydroxypropyl-9- { [(4-chlor-2,6-dimethylphenyl)acetyl] amino} -1,5-dioxaspiro[5.5]undecan-9-carboxylat (Bsp. XVI-4) und Propan-1,3-diyl-bis(9-{ [(4-chlor-2,6-dimethylphenyl)acetyl]amino}-1,5-dioxaspiro[5.5]undecan-9-carboxylat) (Bsp. XVII-4)
[0075]
[0076] To a solution of 5.067 g [15 mmol] of 1-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-4-oxocyclohexanecarboxylic acid in 22.5 ml of chlorobenzene are added 9.31 g [120 mmol] of 1,3-propanediol and 15 drops of concentrated sulfuric acid. The reaction mixture is heated to 95-100°C for 10 hours and then stirred with methylene chloride and water at room temperature. The organic phase is separated, washed three times with water, dried over sodium sulfate, and concentrated in vacuo. 7.37 g of resinous oil are obtained which, according to LC / MS, contains 64% 3-hydroxypropyl-9-{[(4-chloro-2,6-dimethylphenyl)acetyl]-amino}-1,5-dioxaspiro[5.5]undecane-9-carboxylate (69% of theory) and 5.2% propane-1,3-diyl-bis(9-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-1,5-dioxaspiro[5.5]undecane-9-carboxylate) (6% of theory).
[0077] LC / MS (ESI positive): m / e = 454 (MH +< , 1 35< Cl), 907 ([2M+H] +< , 2 35< Cl).
[0078] LC / MS (ESI positive): m / e = 831 (MH +< , 2 35< Cl). Example 6 11-(4-Chlor-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-on (Bsp. XI-1)
[0079]
[0080] A mixture of 1.065 g [2.50 mmol] of 2-hydroxyethyl 8-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate and 0.218 g [0.28 mmol] of ethane-1,2-diyl-bis(8-{[(2,5-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate), prepared as described in Example 1, is initially charged in 5 ml of N,N-dimethylacetamide. 1.576 g [8.75 mmol] of a 30% solution of sodium methylate in methanol is then added dropwise at 75-80°C over a period of 2 minutes. The reaction mixture is stirred at 75-80°C for 55 minutes and then concentrated in vacuo. The residue is dissolved in 30 ml of water, the solution is filtered, and the filtrate is adjusted to pH 4-5 with acetic acid. The precipitated solid is filtered off, washed twice with 5 ml of water each time, and dried. This yields 1.203 g of a light beige solid, which, according to quantitative NMR, consists of 80.7% of the title compound. This results in a yield of 99% of theory, based on the sum of both reactant molecules.
[0081] 1< H-NMR (600 MHz, d 6 -DMSO): δ = 1,35-1,4 (m; 2H), 1,65-1,7 (m; 2H), 1,8-1,9 (m; 4H), 2,05-2,15 (m; 2H). 2,07 (s; 6H), 3,88 (s; 4H), 7,09 (s; 2H), 8,1 (s,br; 1H), 10,5 (s,br; 1H) ppm. Example 7 3-(4-Chlor-2,6-dimethylphenyl)-4-hydroxy-11,11-dimethyl-9,13-dioxa-l-azadispiro[4.2.5.2]pentadec-3-en-2-on (Bsp. XI-2)
[0082]
[0083] 2.550 g [5 mmol] of 3-hydroxy-2,2-dimethylpropyl-9-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-3,3-dimethyl-1,5-dioxaspiro[5.5]undecane-9-carboxylate (Example 3) are initially dissolved in 10 ml of N,N-dimethylacetamide. At 75-80°C, 3.151 g [17.5 mmol] of a 30% solution of sodium methylate in methanol are then added dropwise over a period of 2 minutes. The reaction mixture is stirred at 75-80°C for 42 minutes and then concentrated in vacuo. The residue is dissolved in 60 ml of water, and the solution is adjusted to pH 4-5 with acetic acid. The precipitated solid is filtered off with suction, washed twice with 10 ml of water each time, and dried. This yields 2.32 g of a light beige solid, which, according to HPLC, consists of 76% of the title compound. This corresponds to a yield of 86.9% of theory.
[0084] LC / MS (ESI positive): m / e = 406 (MH +< , 1 35< Cl), 811 ([2M+H] +< , 2 35< Cl). Example 8 12-Hydroxy-11-mesityl-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one (Ex. XI-3)
[0085]
[0086] 2.43 g [6.0 mmol] of 2-hydroxyethyl 8-[(mesitylacetyl)amino]-1,4-dioxaspiro[4.5]decane-8-carboxylate (Example 4) are initially dissolved in 12 ml of N,N-dimethylacetamide. At 75-80°C, 3.78 g [21 mmol] of a 30% solution of sodium methylate in methanol are then added dropwise over 3 minutes. The reaction mixture is stirred at 75-80°C for 6 hours and then concentrated in vacuo. The residue is dissolved in 70 ml of water, and the solution is adjusted to pH 4 with acetic acid. The precipitated solid is filtered off with suction, washed with 12 ml of water, and dried. This gives 1.88 g of a light beige solid, which, according to HPLC, consists of 87% of the title compound. This results in a yield of 79.4% of theory.
[0087] LC / MS (ESI positive): m / e = 344 (MH +< ), 687 ([2M+H] +< ).
[0088] 1< H-NMR (600 MHz, d 6 -DMSO): δ = 1.36-1.38 (m; 2H), 1.67-1.69 (m; 2H), 1.83-1.88 (m; 2H), 2.04 (s; 6H), 2.06-2.1 (m; 2H), 2.2 (s; 3H), 3.88 (s; 4H), 6.81 (s; 2H) ppm. Example 9 3-Hydroxybutan-2-yl-8-{[(2,5-dimethylphenyl)acetyl]amino}-2,3-dimethyl-1,4-dioxaspiro[4.5]decane-8-carboxylate (Ex. XVI-5)
[0089]
[0090] 2.87 g [7.66 mmol] of 8-{[(2,5-dimethylphenyl)acetyl]amino}-2,3-dimethyl-1,4-dioxaspiro[4.5]-decane-8-carboxylic acid is placed in 20 ml of 2,3-butanediol, three drops of concentrated sulfuric acid are added, and the mixture is stirred for 10 hours at 100°C. The reaction mixture is then diluted with methylene chloride at room temperature and extracted twice with water. The organic phase is dried over sodium sulfate and concentrated in vacuo. This gives 4.0 g of a yellowish oil, which, according to HPLC, contains 77.1% of the target product, corresponding to a yield of 90% of theory.
[0091] LC / MS (ESI positiv): m / e = 448 (MH +< ), 895 ([2M+H] +< ). Example 10 11-(2,5-Dimethylphenyl)-12-hydroxy-2,3-dimethyl-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-on (Bsp. XI-4)
[0092]
[0093] 1.54 g [3.45 mmol] of 3-hydroxybutan-2-yl-8-{[(2,5-dimethylphenyl)acetyl]amino}-2,3-dimethyl-1,4-dioxaspiro[4.5]decane-8-carboxylate (Example 9) are initially dissolved in 7 ml of N,N-dimethylacetamide. At 75-80°C, 2.17 g [12.1 mmol] of a 30% solution of sodium methylate in methanol are then added dropwise over 5 minutes. The reaction mixture is stirred at 75-80°C for 90 minutes and then concentrated in vacuo. The residue is dissolved in 40 ml of water, and the solution is adjusted to pH 4-5 with acetic acid. The precipitated solid is filtered off with suction, washed twice with 5 ml of water each time, and dried. This yields 0.70 g of a light beige solid, which, according to HPLC, consists of 82.8% of the title compound. This corresponds to a yield of 47.1% of theory.
[0094] LC / MS (ESI positive): m / e = 358 (MH +< ), 715 ([2M+H] +< ). Example 11 Potassium 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate (Ex. XIX-1)
[0095]
[0096] 141.4 g [0.625 mol] of 9,12-dioxa-1,3-diazadispiro[4.2.4.2]tetradecane-2,4-dione are suspended in 100 ml of water. The mixture is heated to 90°C under an argon atmosphere, and 298.4 g [2.5 mol] of potassium hydroxide in the form of 47% potassium hydroxide solution are added over 15 minutes. The reaction mixture is then stirred under reflux for 24 hours. While continuing to stir, the mixture is cooled to room temperature, and the solid is isolated by filtration through a frit. After drying at 60°C under a vacuum of 1 mbar, 139.0 g of beige solid are obtained. Quantitative NMR: 88.0%. This yields 81.8% of theory. Example 12 Sodium 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate (Ex. XIX-2)
[0097]
[0098] 43.4 g (0.192 mol) of 9,12-dioxa-1,3-diazadispiro[4.2.4.2]tetradecane-2,4-dione are suspended in 30 ml of water. The mixture is heated to 90°C under an argon atmosphere, and 68.3 g (0.768 mol) of sodium hydroxide in the form of 45% sodium hydroxide solution are added over 2 minutes. The reaction mixture is then stirred under reflux for 27.5 hours. While continuing to stir, it is cooled to room temperature, and the solid is isolated by filtration through a frit. After drying at 60°C under a vacuum of 1 mbar, 54.8 g of beige solid are obtained. Quantitative NMR: 72.7%. This yields 93.0% of theory.
[0099] 1< H-NMR (600 MHz, D 2 O): δ = 1.56-1.6 (m, 2H), 1.69-1.75 (m, 2H), 1.75-1.82 (m, 2H), 2.0-2.04 (m, 2H), 4.06 (s, 4H) ppm. Example 13 Sodium 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate (Ex. XIX-2)
[0100]
[0101] 291.8 g [1.29 mol] of 9,12-dioxa-1,3-diazadispiro[4.2.4.2]tetradecane-2,4-dione are suspended in 495 ml of water. The mixture is heated to 90°C under an argon atmosphere, and 773.3 g [8.7 mol] of sodium hydroxide in the form of 45% sodium hydroxide solution are added over a period of 17 minutes. The reaction mixture is then stirred under reflux for 20 hours. While continuing to stir, it is cooled to room temperature, and the solid is isolated by filtration through a frit. After drying at 60°C under a vacuum of 1 mbar, 367.3 g of beige solid are obtained. Quantitative NMR: 76.3%. This yields 97.1% of theory. Example 14 1-{[(4-Chloro-2,6-dimethylphenyl)acetyl]amino}-4-oxocyclohexanecarboxylic acid (Ex. XV-1)
[0102]
[0103] 23.88 g [81.4 mmol] of potassium 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate, 81.6% pure according to quantitative NMR, are placed in 65 ml of water at room temperature, resulting in a pH of approximately 13.6. The solution is cooled to 2°C and adjusted to pH 12.1 with 32% hydrochloric acid. A solution of 17.68 g [81.4 mmol] of (4-chloro-2,6-dimethylphenyl)acetyl chloride in 20 ml of dry tetrahydrofuran is then added dropwise over a period of 70 minutes at 3 to 5°C. Simultaneously, 32% sodium hydroxide solution is added dropwise at a rate such that the pH of the reaction mixture remains between 11.8 and 12.5 (10.93 g consumed [87.4 mmol]). The reaction mixture is then stirred for a further 60 minutes at 3 to 5°C, allowed to warm to room temperature, diluted with 30 ml of water, and adjusted to approximately 1.8 with vigorous stirring. The precipitated solid is washed twice with 30 ml of water each time and then dried in vacuo at approximately 60°C.29.31 g of almost colorless solid are obtained.
[0104] Quantitative NMR: 88.7%, resulting in a yield of 83.6% of theory.
[0105] 1< H-NMR (600 MHz, d 6 -DMSO): δ = 1.56-1.58 (m, 2H), 1.64-1.69 (m, 2H), 1.84-1.9 (m, 2H), 2.01-2.03 (m, 2H), 2.24 (s, 6H), 3.54 (s, 2H),3.86 (s, 4H), 7.05 (s, 2H), 8.17 (s, 1H), 12 (s, br, 1H) ppm. Comparison example 1 Methyl 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate
[0106]
[0107] 57 g of thionyl chloride are added dropwise to a suspension of 64.5 g of 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylic acid in 960 ml of methanol at 5 to 10°C over 60 minutes. The mixture is warmed to 40 to 45°C and stirred at this temperature for 48 hours. After cooling to 5°C, the solid is filtered off with suction, washed with 60 ml of cold methanol, and dried. The solid is then added, with stirring, to a solution of 54 g of potassium carbonate in 220 ml of water and stirred for approximately 30 minutes. The mixture is then extracted five times with 200 ml of methylene chloride each time. The combined organic phases are dried over sodium sulfate and concentrated in a rotary evaporator at 30°C. 65.8 g of dark oil is obtained, which according to GC / MS after silylation contains approximately 52.7% of the title compound and 35.7% methyl 1-amino-4,4-dimethoxycyclohexanecarboxylate. Comparison example 2 Methyl 8-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino} -1,4-dioxaspiro[4.5]decane-8-carboxylate
[0108]
[0109] To a solution of 33.4 g of the product from Comparative Example 1 in 490 ml of dry acetonitrile, 38 g of potassium carbonate are added at room temperature. A solution of 30 g of (4-chloro-2,6-dimethylphenyl)acetyl chloride in 60 ml of dry acetonitrile is then added over 1 hour at a temperature of 5 to 10°C. The mixture is stirred for a further 2 hours at 5°C and overnight at room temperature. The reaction mixture is added to approximately 2 liters of water, stirred for 1 hour at room temperature, and the precipitated solid is filtered off, washed with 250 ml of water, and dried at 50°C under vacuum. 53.2 g of white solid is obtained which, according to GC, contains 66.4% of the title compound, 18.2% of methyl 1-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-4,4-dimethoxycyclohexanecarboxylate and 12.4% of methyl 1-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-4-oxocyclohexanecarboxylate. Comparison example 3 Methyl 8-{[(4-chloro-2,6-dimethylphenyl)acetyl]amino}-1,4-dioxaspiro[4.5]decane-8-carboxylate
[0110]
[0111] A solution of 28.0 g of crude methyl 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate hydrochloride, which is approximately 69% pure and additionally contains approximately 21% methyl 1-amino-4,4-dimethoxycyclohexanecarboxylate, in 90 ml of water is cooled to 10°C and adjusted to a pH of approximately 7.2 with 1N sodium hydroxide solution. 10.92 g of sodium bicarbonate and 100 ml of xylene are added, followed by a solution of 23.88 g of (4-chloro-2,6-dimethylphenyl)acetyl chloride in 27 ml of xylene being added dropwise over the course of 1 hour at 5 to 10°C. The mixture is then stirred for a further 30 minutes at 5 to 10°C, then heated to 65°C and stirred at this temperature for 1 hour. The pH is maintained at 7 by adding 1N sodium hydroxide solution. After cooling to room temperature, the precipitated solid is filtered off with suction and washed successively with 25 ml of xylene and twice with 25 ml of petroleum ether. After drying in vacuum at 50°C, a beige solid is obtained, which, according toHPLC analysis contains 78.8% of the title compound, 6.6% methyl 1-{[(4-chloro-2,6-dimethylphenyl)acetyl] amino} -4,4-dimethoxycyclohexanecarboxylate and 11.1% methyl 1-{[(4-chloro-2,6-dimethylphenyl)acetyl] amino} -4-oxocyclohexanecarboxylate. Comparison example 4 11 -(4-Chloro-2,6-dimethylphenyl)- 12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2] tetradec-11 -en- 10-one
[0112]
[0113] A solution of 42.0 g of crude methyl 8-amino-1,4-dioxaspiro[4.5]decane-8-carboxylate hydrochloride, which is approximately 69% pure and additionally contains approximately 21% methyl 1-amino-4,4-dimethoxycyclohexanecarboxylate, in 135 ml of water is cooled to 10°C and adjusted to a pH of approximately 7.2 with 1 N sodium hydroxide solution. 16.4 g of sodium bicarbonate and 150 ml of xylene are added, followed by a solution of 29.31 g of (4-chloro-2,6-dimethylphenyl)acetyl chloride in 36 ml of xylene being added dropwise over the course of 1 hour at 5 to 10°C. The mixture is then stirred for a further 30 minutes at 5 to 10°C, then heated to 65°C and stirred at this temperature for 1 hour. The pH is maintained at 7 by adding 1 N sodium hydroxide solution. The water is then removed by azeotropic distillation using a water separator under a vacuum of approximately 250 to 110 mbar. The bottoms are allowed to cool to approximately 50°C, and then 110 ml of N,N-dimethylacetamide is added. The xylene is then distilled off under a slight vacuum at a boiling point of approximately 70°C.The mixture is then cooled to 50°C, and 36.47 g of 30% methanolic sodium methylate solution are added dropwise over 10 minutes. The mixture is warmed to 70°C, and the methanol is distilled off under a slight vacuum over approximately 2 hours. The N,N-dimethylacetamide is then largely distilled off under vacuum. The residue is dissolved in 500 ml of water, and the solution is adjusted to a pH of approximately 5 by adding glacial acetic acid. The precipitated solid is filtered off with suction, washed twice with 80 ml of water each time, and dried under vacuum at 50°C. 51.95 g of beige solid is obtained which, according to LC / MS analysis, contains 71.3% of the title compound, 11.1% of 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8,8-dimethoxy-1-azaspiro[4.5]dec-3-en-2-one and 1.9% of 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-1-azaspiro[4.5]dec-3-en-2,8-dione.
Claims
1. Process for preparing compounds of the formula (XI) where R1, R2, R3, R4, R5, R6 independently of one another represent hydrogen, methyl, ethyl or phenyl, R8, R9, R10, R11, R12 independently of one another represent hydrogen, methyl, ethyl, fluoroalkyl having one or 2 carbon atoms and one to five fluorine atoms, halogen, methoxy, ethoxy, trifluoromethoxy or optionally methyl-, ethyl-, methoxy-, ethoxy- or halogen-substituted phenyl and n represents 0 or 1, characterized in that compounds of the formula (III) where n and R1 to R6 have the meanings given above, are reacted in the presence of a base with compounds of the formula (VII) where R8 to R12 have the meanings given above, to give compounds of the formula (XV) where n, R1 to R6 and R8 to R12 have the meanings given above; the compounds of the formula (XV) are then esterified with compounds of the formula (XIV) HO - (CR1R2)n - CR3R4 - CR5R6 -OH (XIV), where n and R1 to R6 have the meanings given above and are, in the concrete individual case, identical to those in the compound of the general formula (XV), in the presence of an acid as catalyst, to give the compounds of the formulae (XVI) and (XVII) where n, R1 to R6 and R8 to R12 have the meanings given above and both n and the corresponding radicals R1 to R6 and R8 to R12 at the two positions of the compounds of the formulae (XVI) or (XVII) are identical; the compounds of the formulae (XVI) and (XVII) in which n, R1 to R6 and R8 to R12 have the meanings given above, are then converted by reaction with a strong base into the compounds of the formula (XI) where n, R1 to R6 and R8 to R12 have the meanings given above.
2. Process according to Claim 1, where R1 to R6 independently of one another represent hydrogen, methyl or ethyl, R8 to R12 independently of one another represent hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy, trifluoromethoxy or optionally methyl-, ethyl-, methoxy-, ethoxy-, fluorine-, chlorine- or bromine-substituted phenyl, n represents 0 or 1.
3. Process according to Claim 1, where R1 to R6 independently of one another represent hydrogen or methyl, R8 to R12 independently of one another represent hydrogen, methyl, ethyl, fluorine, chlorine, methoxy, ethoxy or optionally methyl-, ethyl-, methoxy-, ethoxy-, fluorine- or chlorine-substituted phenyl, n represents 0 or 1.
4. Process for preparing compounds of the formulae (XVI) and (XVII) where R1 to R6 and R8 to R12 have the meanings given above and the corresponding radicals R1 to R6 and R8 to R12 at the two positions of the compounds of the general formulae (XVI) or (XVII) are identical and n represents 0 or 1 and is identical at the two positions of the compounds of the formulae (XVI) or (XVII), characterized in that compound of the formula (XVIII) where R8 to R12 have the meanings given above, is reacted with compounds of the formula (XIV) HO - (CR1R2)n -CR3R4- CR5R6- OH (XIV) , where n and R1 to R6 have the meanings given above and are, in the concrete individual case, identical to those in the compound of the formulae (XVI) or (XVII), in the presence of an acid as catalyst.
5. Compound of the formula (XV-1) 6. Compounds of the formulae (XVI) and (XVII) where R1 to R6 independently of one another represent hydrogen, methyl, ethyl or phenyl and are identical at the two positions of the compounds of the formulae (XVI) or (XVII), n represents 0 or 1 and is identical at the two positions of the compounds of the formulae (XVI) or (XVII), and R8 to R12 independently of one another represent hydrogen, methyl, ethyl, fluoroalkyl having one or 2 carbon atoms and one to five fluorine atoms, halogen, methoxy, ethoxy, trifluoromethoxy or optionally methyl-, ethyl-, methoxy-, ethoxy- or halogen-substituted phenyl and are identical at the two positions of the compounds of the formulae (XVI) or (XVII).
7. Compounds of the formulae (XVI) and (XVII) according to Claim 6, where R3 to R6 independently of one another represent hydrogen or methyl and are identical at the two positions of the compounds of the formulae (XVI) or (XVII), n represents 0 and R8 to R12 independently of one another represent hydrogen, methyl or chlorine and are identical at the two positions of the compounds of the formulae (XVI) or (XVII).
8. Compounds of the formulae (XVI) and (XVII) according to Claim 6, where R3 to R6 represent hydrogen, n represents 0 and R8 represents methyl, R9 represents hydrogen, R10 represents chlorine, R11 represents hydrogen, R12 represents methyl.
